Test 1 Flashcards
Hematopoietic stem cell transplant (HSCT) types
autologous, syngeneic, allogenic
autologous HSCT
donating own stem cells
syngeneic HSCT
identical twin donates stem cells
allogenic HSCT
make a match from non-related donor for stem cell transplant that’s
hemrarthrosis management
- during bleeding episodes, elevate and immobilize the joint
- ice
- analgesics
- range-of-motion exercises after the bleeding stops will help to prevent contractures
- physical therapy
- avoid obesity to minimize joint stress
Hemophilia A: etiology and pathogenesis
- etiology: x-linked recessive gene
- pathogenesis: factor 8 deficiency (90%), defective factor 8 (10%)
Four types of sickle cell anemia crises
- vasoocclusive: obstruction, vasospasm, thrombosis, & infarction
- sequestration: large amounts of blood pool in liver and spleen (children)
- aplastic: profound anemia d/t diminished erythropoesis
- hyperhemolytic: unusual, occurs with certain drugs or infections
5 factors associated with sickling
- exposure to cold
- infection
- stress
- dehydration
- acidosis
idiopathic thrombocytopenia purpura has platelet count of less than
less than 100,000 platelet count, can be drug induced
aplastic anemia 3 differentiating assessment findings
- infection of skin/mucous membranes
- bleeding from gums, nose, vagina, rectum
- retinal hemorrhage
immune mediated atrophic gastritis–> destruction of parietal cells–> decreased production of intrinsic factors and binding of intrinsic factors B12–>decreased absorption in the ileum–>large, flimsy RBC’s
pernicious anemia pathogenisis
- low serum iron and ferritin
- elevated total iron binding capacity (TIBC)
- complete blood count: decreased RBC’s
- low HGB & HCT
diagnosis of iron deficiency anemia
2 types of hemoglobin
0-6 months of age: Hemoglobin F
6 months of age and up: Hemoglobin A
implement bleeding precautions if platelet count is…
-platelet count less than 50,000
spontaneous hemorrhage occurs when platelet count is less than…
-platelet count less than 20,000
types of radiation therapy
- external ration or “teletherapy”
- internal radiation or “brachytherapy”
brachytherapy radiation source
direct radiation source in continuous contact with tumor tissues for a specific time
- binds to target antigens (often specific cell surface membrane proteins)
- prevents protein from functioning, prevents cell division
- ex: Rituximab (Rituxan)
monoclonal antibodies
Target mammalian target of rapamycin (mTOR)
-ex: Torisel
Angiogenesis inhibitors
Prevent formation of a large complex of proteins into cells
-Bortezomib (Velcade)
Proteasome inhibitors
Inhibit activity of specific kinases in cancer cells and tumor blood vessels
-Sunitib (Sutent)
Multikinase inhibitors (MKI’s)
Bind to vascular endothelial growth factor (VEGF), prevent binding of VEGF with its receptors on surfaces of endothelial cells present in blood vessels
-ex: Bevacizumab (Avastin)
Vascular endothelial growth factor receptor inhibitors
Block epidermal growth factor from binding to cell surface receptor
-Trastuzumab (Herceptin)
Epidermal growth factor/receptor inhibitors
TNM staging classification TO, Tis, T1, T2, T3, T4
TO: no evidence
TIS: tumor insitu
T1, T2, T3, T4: ascending degrees of tumor size and involvement